[HTML][HTML] Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
B Kovacech, L Fialova, P Filipcik, R Skrabana… - …, 2022 - thelancet.com
Background The emergence of new SARS-CoV-2 variants of concern B. 1.1. 7 (Alpha), B.
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
B Kovacech, L Fialova, P Filipcik… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The emergence of new SARS-CoV-2 variants of concern B. 1.1. 7 (Alpha), B.
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
[HTML][HTML] Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
B Kovacech, L Fialova, P Filipcik, R Skrabana… - eBioMedicine, 2022 - Elsevier
Background The emergence of new SARS-CoV-2 variants of concern B. 1.1. 7 (Alpha), B.
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
B Kovacech, L Fialova, P Filipcik, R Skrabana… - 2022 - muni.cz
Background: The emergence of new SARS-CoV-2 variants of concern B. 1.1. 7 (Alpha), B.
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern.
B Kovacech, L Fialova, P Filipcik, R Skrabana… - Ebiomedicine, 2022 - europepmc.org
Background The emergence of new SARS-CoV-2 variants of concern B. 1.1. 7 (Alpha), B.
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
[HTML][HTML] Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
B Kovacech, L Fialova, P Filipcik, R Skrabana… - …, 2022 - ncbi.nlm.nih.gov
Background The emergence of new SARS-CoV-2 variants of concern B. 1.1. 7 (Alpha), B.
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern.
B Kovacech, L Fialova, P Filipcik, R Skrabana… - Ebiomedicine, 2022 - europepmc.org
Background The emergence of new SARS-CoV-2 variants of concern B. 1.1. 7 (Alpha), B.
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
B Kovacech, L Fialova, P Filipcik… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The emergence of new SARS-CoV-2 variants of concern B. 1.1. 7 (Alpha), B.
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …
1.351 (Beta), P. 1 (Gamma) and B. 1.617. 2 (Delta) that harbor mutations in the viral S …